Nicholas J. Vogelzang, MD, FASCO, FACP is a distinguished medical oncologist at Comprehensive Cancer Centers of Nevada, located in Las Vegas, Nevada.
Dr. Vogelzang specializes in Genitourinary Malignancies, specifically kidney, bladder, prostate and testicular cancers, as well as thoracic and lung cancers. Dr. Vogelzang is a renowned cancer researcher, particularly focusing on phase I trials for all solid tumors and new therapies for patients with metastatic prostate, bladder and kidney cancers. He has authored, co-authored and peer-reviewed more than 500 articles on advanced treatment options for various carcinomas and genitourinary malignancies. Dr. Vogelzang was the lead editor of the Comprehensive Textbook of Genitourinary Oncology for 14 years before serving as the Associate Editor of the Kidney Cancer Journal, UP-TO-DATE and Clinical Genitourinary Cancer. He has earned numerous awards, including Distinguished Physician of the Year by the Nevada State Medical Association and the Gold Certificate of Excellence by the National Cancer Institute. Dr. Vogelzang has been featured in various local and national media outlets highlighting his cancer research, including The New York Times, The New England Journal of Medicine, USA Today and Nature. Currently, Dr. Vogelzang serves as Clinical Professor of Medicine at the University of Nevada School of Medicine (UNLV).
Dr. Vogelzang received his medical degree from the University of Illinois in Chicago after completing an internship and his residency in internal medicine at Rush Presbyterian St. Luke's Medical Center in Chicago. Following his residency, Dr. Vogelzang completed his fellowship in medical oncology at the University of Minnesota in Minneapolis.
Interview opportunity courtesy of Bayer
